期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

18F-FDGPET／CT代谢活性参数及其在淋巴瘤中的应用 被引量：7

Metabolic parameters of lSF-FDG PET/CT and their application in lymphoma
原文传递
导出
摘要 PET／CT中PET图像分析方法主要为视觉评估法与定量或半定量参数分析法，其中，定量或半定量分析参数主要包括SUV、肿瘤代谢体积和病灶糖酵解总量。PET／CT集功能显像与解剖显像于一体，成为淋巴瘤最重要的影像检查设备。笔者主要综述18F-FDGPET／CT常用代谢活性参数及其在淋巴瘤中的应用。 PET image analysis mainly includes the visual assessment and quantitative or semiquantitative approaches, and the quantitative or semiquantitative parameters include SUV, metabolic tumor volume and total lesion glyeolysis. PET/CT provides both metabolic and morphologie information, and becomes the most important imaging armamentarium in lymphoma. This article reviews major metabolic activity parameters of lSF-FDG PET/CT and their application in lymphoma.
作者 胡娜 吴永港 肖立志 谭延林 王云华
机构地区 中南大学湘雅二医院PET/CT中心
出处 《国际放射医学核医学杂志》 2015年第4期342-347,共6页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 淋巴瘤 正电子发射断层显像术 体层摄影术 X线计算机 代谢活性参数 Lymphoma Positron-emission tomography Tomography, X-ray computed Metabol- ic activity parameter
分类号 R733.1 [医药卫生—肿瘤] R730.44 [医药卫生—肿瘤]
  • 相关文献

参考文献45

  • 1Jaskowiak C J, Bianco JA, Perlman SB, et al. Influence of Recon- struction iterations on ^18F-FDG PET/CT standardized uptake values [J]. J Nucl Med, 2005, 46(3 ) : 424-428.
  • 2Allal AS, Dulguerov P, Allaoua M, et al. Standardized uptake value of 2-[^18F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy[J]. J Clin Oncol, 2002, 20(5) : 1398-1404.
  • 3Halfpenny W, Hain SF, Biassoni L, et al. FDG-PET. A possible prognostic factor in head and neck cancer[J]. Br J Cancer, 2002, 86 (4): 512-516.
  • 4Cistaro A, Quartuccio N, Mojtahedi A, et al. Prediction of 2 years- survival in patients with stage I and II non-small cell lung cancer utilizing ^18F-FDG PET/CT SUV quantification[J]. Radiol Oncol, 2013, 47(3) : 219-223.
  • 5Schinagl DA, Vogel WV, Hoffmann AL, et al. Comparison of five segmentation tools for ^18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer [J]. Int J Radiat Oncol Biol Phys, 2007, 69(4) : 1282-1289.
  • 6Werner-Wasik M, Nelson AD, Choi W, et al. What is the best way to contour lung tumors on PET scans Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom[J]. Int J Radiat Oncol Biol Phys, 2012, 82(3) : 1164-1171.
  • 7Boellaard R, O'doherty M J, Weber WA, et al. FDG PET and PET/ CT: EANM procedure guidelines for tumour PET imaging: ver- sion 1.0[J]. Eur J Nucl Med Mol Imaging, 2010, 37 (1) : 181-200.
  • 8Meignan M, Sasanelli M, Casasnovas RO, et al. Metabolic tumour volumes measured at staging in lymphoma: methodological evalu- ation on phantom experiments and patients[J]. Eur J Nucl Med Mol Imaging, 2014, 41 (6) : 1113-1122.
  • 9Daisne JF, Duprez T, Weynand B, et al. Tumor volume in pharyngo- laryngeal squamous cell carcinoma: comparison at CT, Mr imag- ing, and FDG PET and validation with surgical specimen[J]. Radi- ology, 2004, 233(1 ) : 93-100.
  • 10Lee HY, Hyun SH, Lee KS, et al. Volume-based parameter of ^18F- FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications[J]. Ann Surg On- col, 2010, 17(10) : 2787-2794.

二级参考文献17

  • 1张玉晶,胡伟汉,刘慧,陈尔成,任忠敏,夏云飞,崔念基.鼻型NK/T细胞淋巴瘤的临床和预后分析[J].中华肿瘤杂志,2006,28(1):50-53. 被引量：21
  • 2王碧芸,洪小南,印季良,陆洪芬,李小秋,马学军,郭晔.鼻腔NK／T细胞淋巴瘤的预后因素分析[J].中华肿瘤杂志,2006,28(7):523-525. 被引量：14
  • 3Miller TP, Grogan TM, Dahlberg S, et al. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non- Hodgkin's lymphomas: a prospective Southwest Oncology Group trial. Blood, 1994, 83 : 1460-1466.
  • 4Shou Y, Lu J, Chen T, et al. Correlation of fluomdeoxyglucose uptake and tumor-proliferating antigen Ki-67 in lymphomas. J Cancer Res Ther, 2012, 8:96-102.
  • 5Hofman MS, Hicks RJ. Using positron emission tomography to assess tumor proliferation in non-Hodgkin lymphoma. Leuk Lymphoma, 2010, 51:183-185.
  • 6Chihara D, Oki Y, Onoda H, et al. High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma. Int J Hematol, 2011, 93:502-508.
  • 7Ngeow JY, Quek RH, Ng DC, et al. High SUV uptake on FDG- PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma.Ann Oncol, 2009, 20 : 1543-1547.
  • 8Chan WK, Au WY, Wong CY, et al. Metabolic activity measured by F-18 FDG PET in natural killer-cell lymphoma compared to aggressive B- and T-cell lymphomas. Clin Nuel Med, 2010, 35 : 571-575.
  • 9Salles G, de Jong D, Xie W, et al. Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma : a study from the Lunenburg Lymphoma Biomarker Consortium. Blood, 2011, 117:7070-7078.
  • 10Watanabe R, Tomita N, Takeuchi K, et al. SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma. Leuk Lymphoma, 2010, 51: 279-283.

共引文献10

同被引文献36

引证文献7

二级引证文献30

国际放射医学核医学杂志
2015年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部